nodes	percent_of_prediction	percent_of_DWPC	metapath
Etonogestrel—Danazol—Prednisone—systemic scleroderma	0.33	0.583	CrCrCtD
Etonogestrel—Methyltestosterone—Prednisone—systemic scleroderma	0.236	0.416	CrCrCtD
Etonogestrel—Danazol—CCL2—systemic scleroderma	0.00399	1	CrCbGaD
Etonogestrel—PGR—artery—systemic scleroderma	0.00276	0.201	CbGeAlD
Etonogestrel—PGR—blood vessel—systemic scleroderma	0.00215	0.157	CbGeAlD
Etonogestrel—ESR1—blood vessel—systemic scleroderma	0.00168	0.122	CbGeAlD
Etonogestrel—SHBG—connective tissue—systemic scleroderma	0.00122	0.0891	CbGeAlD
Etonogestrel—PGR—connective tissue—systemic scleroderma	0.0011	0.0803	CbGeAlD
Etonogestrel—PGR—smooth muscle tissue—systemic scleroderma	0.00101	0.0734	CbGeAlD
Etonogestrel—ESR1—connective tissue—systemic scleroderma	0.000862	0.0628	CbGeAlD
Etonogestrel—ESR1—smooth muscle tissue—systemic scleroderma	0.000788	0.0574	CbGeAlD
Etonogestrel—PGR—lung—systemic scleroderma	0.000665	0.0484	CbGeAlD
Etonogestrel—ESR1—digestive system—systemic scleroderma	0.000622	0.0454	CbGeAlD
Etonogestrel—ESR1—lung—systemic scleroderma	0.00052	0.0379	CbGeAlD
Etonogestrel—Rash—Mometasone—systemic scleroderma	0.000418	0.001	CcSEcCtD
Etonogestrel—Asthenia—Captopril—systemic scleroderma	0.000418	0.001	CcSEcCtD
Etonogestrel—Dermatitis—Mometasone—systemic scleroderma	0.000418	0.001	CcSEcCtD
Etonogestrel—Decreased appetite—Leflunomide—systemic scleroderma	0.000417	0.001	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000417	0.001	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000416	0.000998	CcSEcCtD
Etonogestrel—Headache—Mometasone—systemic scleroderma	0.000416	0.000998	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000415	0.000995	CcSEcCtD
Etonogestrel—Insomnia—Mycophenolic acid—systemic scleroderma	0.000414	0.000995	CcSEcCtD
Etonogestrel—Fatigue—Leflunomide—systemic scleroderma	0.000414	0.000994	CcSEcCtD
Etonogestrel—Oedema—Lisinopril—systemic scleroderma	0.000413	0.000991	CcSEcCtD
Etonogestrel—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000413	0.000991	CcSEcCtD
Etonogestrel—Pruritus—Captopril—systemic scleroderma	0.000412	0.00099	CcSEcCtD
Etonogestrel—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000411	0.000987	CcSEcCtD
Etonogestrel—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000411	0.000987	CcSEcCtD
Etonogestrel—Constipation—Leflunomide—systemic scleroderma	0.000411	0.000986	CcSEcCtD
Etonogestrel—Pain—Leflunomide—systemic scleroderma	0.000411	0.000986	CcSEcCtD
Etonogestrel—Infection—Lisinopril—systemic scleroderma	0.00041	0.000984	CcSEcCtD
Etonogestrel—Somnolence—Mycophenolic acid—systemic scleroderma	0.000407	0.000978	CcSEcCtD
Etonogestrel—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000405	0.000972	CcSEcCtD
Etonogestrel—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000403	0.000968	CcSEcCtD
Etonogestrel—Abdominal pain—Azathioprine—systemic scleroderma	0.000402	0.000965	CcSEcCtD
Etonogestrel—Body temperature increased—Azathioprine—systemic scleroderma	0.000402	0.000965	CcSEcCtD
Etonogestrel—Skin disorder—Lisinopril—systemic scleroderma	0.000401	0.000962	CcSEcCtD
Etonogestrel—Malaise—Mycophenolate mofetil—systemic scleroderma	0.0004	0.000959	CcSEcCtD
Etonogestrel—Diarrhoea—Captopril—systemic scleroderma	0.000399	0.000957	CcSEcCtD
Etonogestrel—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000398	0.000956	CcSEcCtD
Etonogestrel—Irritability—Methotrexate—systemic scleroderma	0.000398	0.000955	CcSEcCtD
Etonogestrel—Feeling abnormal—Leflunomide—systemic scleroderma	0.000396	0.00095	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000396	0.000949	CcSEcCtD
Etonogestrel—Fatigue—Mycophenolic acid—systemic scleroderma	0.000395	0.000948	CcSEcCtD
Etonogestrel—Mood swings—Methotrexate—systemic scleroderma	0.000395	0.000948	CcSEcCtD
Etonogestrel—Nausea—Mometasone—systemic scleroderma	0.000394	0.000946	CcSEcCtD
Etonogestrel—Anorexia—Lisinopril—systemic scleroderma	0.000393	0.000944	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000393	0.000943	CcSEcCtD
Etonogestrel—Weight increased—Prednisone—systemic scleroderma	0.000392	0.000941	CcSEcCtD
Etonogestrel—Constipation—Mycophenolic acid—systemic scleroderma	0.000392	0.00094	CcSEcCtD
Etonogestrel—Pain—Mycophenolic acid—systemic scleroderma	0.000392	0.00094	CcSEcCtD
Etonogestrel—Weight decreased—Prednisone—systemic scleroderma	0.00039	0.000936	CcSEcCtD
Etonogestrel—Cough—Mycophenolate mofetil—systemic scleroderma	0.000387	0.000928	CcSEcCtD
Etonogestrel—Dizziness—Captopril—systemic scleroderma	0.000385	0.000925	CcSEcCtD
Etonogestrel—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000384	0.000921	CcSEcCtD
Etonogestrel—Depression—Prednisone—systemic scleroderma	0.000383	0.00092	CcSEcCtD
Etonogestrel—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000382	0.000918	CcSEcCtD
Etonogestrel—Urticaria—Leflunomide—systemic scleroderma	0.000382	0.000916	CcSEcCtD
Etonogestrel—Body temperature increased—Leflunomide—systemic scleroderma	0.00038	0.000911	CcSEcCtD
Etonogestrel—Abdominal pain—Leflunomide—systemic scleroderma	0.00038	0.000911	CcSEcCtD
Etonogestrel—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000378	0.000906	CcSEcCtD
Etonogestrel—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000377	0.000905	CcSEcCtD
Etonogestrel—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000377	0.000905	CcSEcCtD
Etonogestrel—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000377	0.000904	CcSEcCtD
Etonogestrel—Breast disorder—Methotrexate—systemic scleroderma	0.000377	0.000904	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000376	0.000902	CcSEcCtD
Etonogestrel—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000376	0.000902	CcSEcCtD
Etonogestrel—Hypersensitivity—Azathioprine—systemic scleroderma	0.000375	0.000899	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000375	0.000899	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000375	0.000899	CcSEcCtD
Etonogestrel—Insomnia—Lisinopril—systemic scleroderma	0.000373	0.000896	CcSEcCtD
Etonogestrel—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000373	0.000894	CcSEcCtD
Etonogestrel—Paraesthesia—Lisinopril—systemic scleroderma	0.000371	0.000889	CcSEcCtD
Etonogestrel—Vomiting—Captopril—systemic scleroderma	0.00037	0.000889	CcSEcCtD
Etonogestrel—Rash—Captopril—systemic scleroderma	0.000367	0.000882	CcSEcCtD
Etonogestrel—Dermatitis—Captopril—systemic scleroderma	0.000367	0.000881	CcSEcCtD
Etonogestrel—Somnolence—Lisinopril—systemic scleroderma	0.000367	0.000881	CcSEcCtD
Etonogestrel—Headache—Captopril—systemic scleroderma	0.000365	0.000876	CcSEcCtD
Etonogestrel—Dyspepsia—Lisinopril—systemic scleroderma	0.000363	0.000872	CcSEcCtD
Etonogestrel—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000362	0.000869	CcSEcCtD
Etonogestrel—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000362	0.000869	CcSEcCtD
Etonogestrel—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000362	0.000868	CcSEcCtD
Etonogestrel—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000362	0.000868	CcSEcCtD
Etonogestrel—Asthma—Methotrexate—systemic scleroderma	0.00036	0.000865	CcSEcCtD
Etonogestrel—Infection—Mycophenolate mofetil—systemic scleroderma	0.000359	0.000862	CcSEcCtD
Etonogestrel—Decreased appetite—Lisinopril—systemic scleroderma	0.000359	0.000861	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000356	0.000855	CcSEcCtD
Etonogestrel—Fatigue—Lisinopril—systemic scleroderma	0.000356	0.000854	CcSEcCtD
Etonogestrel—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000355	0.000851	CcSEcCtD
Etonogestrel—Hypersensitivity—Leflunomide—systemic scleroderma	0.000354	0.000849	CcSEcCtD
Etonogestrel—Constipation—Lisinopril—systemic scleroderma	0.000353	0.000847	CcSEcCtD
Etonogestrel—Pain—Lisinopril—systemic scleroderma	0.000353	0.000847	CcSEcCtD
Etonogestrel—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000351	0.000843	CcSEcCtD
Etonogestrel—Diarrhoea—Azathioprine—systemic scleroderma	0.000348	0.000835	CcSEcCtD
Etonogestrel—CYP3A4—digestive system—systemic scleroderma	0.000347	0.0253	CbGeAlD
Etonogestrel—Haemoglobin—Prednisone—systemic scleroderma	0.000347	0.000832	CcSEcCtD
Etonogestrel—Nausea—Captopril—systemic scleroderma	0.000346	0.000831	CcSEcCtD
Etonogestrel—Haemorrhage—Prednisone—systemic scleroderma	0.000345	0.000828	CcSEcCtD
Etonogestrel—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000345	0.000827	CcSEcCtD
Etonogestrel—Asthenia—Leflunomide—systemic scleroderma	0.000345	0.000827	CcSEcCtD
Etonogestrel—Feeling abnormal—Lisinopril—systemic scleroderma	0.00034	0.000816	CcSEcCtD
Etonogestrel—Pruritus—Leflunomide—systemic scleroderma	0.00034	0.000816	CcSEcCtD
Etonogestrel—Connective tissue disorder—Prednisone—systemic scleroderma	0.000339	0.000814	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000337	0.00081	CcSEcCtD
Etonogestrel—Dysuria—Methotrexate—systemic scleroderma	0.000337	0.000808	CcSEcCtD
Etonogestrel—Dizziness—Azathioprine—systemic scleroderma	0.000336	0.000807	CcSEcCtD
Etonogestrel—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000335	0.000804	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000329	0.000791	CcSEcCtD
Etonogestrel—Asthenia—Mycophenolic acid—systemic scleroderma	0.000329	0.000789	CcSEcCtD
Etonogestrel—Diarrhoea—Leflunomide—systemic scleroderma	0.000329	0.000789	CcSEcCtD
Etonogestrel—Urticaria—Lisinopril—systemic scleroderma	0.000328	0.000787	CcSEcCtD
Etonogestrel—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000327	0.000785	CcSEcCtD
Etonogestrel—Body temperature increased—Lisinopril—systemic scleroderma	0.000326	0.000783	CcSEcCtD
Etonogestrel—Abdominal pain—Lisinopril—systemic scleroderma	0.000326	0.000783	CcSEcCtD
Etonogestrel—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000325	0.000779	CcSEcCtD
Etonogestrel—Pruritus—Mycophenolic acid—systemic scleroderma	0.000324	0.000778	CcSEcCtD
Etonogestrel—Vomiting—Azathioprine—systemic scleroderma	0.000323	0.000776	CcSEcCtD
Etonogestrel—Eye disorder—Prednisone—systemic scleroderma	0.000322	0.000774	CcSEcCtD
Etonogestrel—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000321	0.000772	CcSEcCtD
Etonogestrel—Infestation NOS—Methotrexate—systemic scleroderma	0.000321	0.000771	CcSEcCtD
Etonogestrel—Infestation—Methotrexate—systemic scleroderma	0.000321	0.000771	CcSEcCtD
Etonogestrel—Rash—Azathioprine—systemic scleroderma	0.000321	0.00077	CcSEcCtD
Etonogestrel—Dermatitis—Azathioprine—systemic scleroderma	0.00032	0.000769	CcSEcCtD
Etonogestrel—Depression—Methotrexate—systemic scleroderma	0.00032	0.000769	CcSEcCtD
Etonogestrel—Headache—Azathioprine—systemic scleroderma	0.000319	0.000765	CcSEcCtD
Etonogestrel—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000318	0.000764	CcSEcCtD
Etonogestrel—Dizziness—Leflunomide—systemic scleroderma	0.000318	0.000762	CcSEcCtD
Etonogestrel—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000314	0.000754	CcSEcCtD
Etonogestrel—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000313	0.000752	CcSEcCtD
Etonogestrel—Angiopathy—Prednisone—systemic scleroderma	0.000313	0.000751	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000312	0.000749	CcSEcCtD
Etonogestrel—Immune system disorder—Prednisone—systemic scleroderma	0.000312	0.000748	CcSEcCtD
Etonogestrel—Pain—Mycophenolate mofetil—systemic scleroderma	0.000309	0.000742	CcSEcCtD
Etonogestrel—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000309	0.000742	CcSEcCtD
Etonogestrel—Vomiting—Leflunomide—systemic scleroderma	0.000305	0.000733	CcSEcCtD
Etonogestrel—Alopecia—Prednisone—systemic scleroderma	0.000305	0.000732	CcSEcCtD
Etonogestrel—Hypersensitivity—Lisinopril—systemic scleroderma	0.000304	0.00073	CcSEcCtD
Etonogestrel—Dizziness—Mycophenolic acid—systemic scleroderma	0.000303	0.000727	CcSEcCtD
Etonogestrel—Rash—Leflunomide—systemic scleroderma	0.000303	0.000727	CcSEcCtD
Etonogestrel—Dermatitis—Leflunomide—systemic scleroderma	0.000303	0.000726	CcSEcCtD
Etonogestrel—Mental disorder—Prednisone—systemic scleroderma	0.000302	0.000725	CcSEcCtD
Etonogestrel—Nausea—Azathioprine—systemic scleroderma	0.000302	0.000725	CcSEcCtD
Etonogestrel—Headache—Leflunomide—systemic scleroderma	0.000301	0.000722	CcSEcCtD
Etonogestrel—Erythema—Prednisone—systemic scleroderma	0.0003	0.000721	CcSEcCtD
Etonogestrel—Malnutrition—Prednisone—systemic scleroderma	0.0003	0.000721	CcSEcCtD
Etonogestrel—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000298	0.000715	CcSEcCtD
Etonogestrel—Asthenia—Lisinopril—systemic scleroderma	0.000296	0.000711	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000296	0.00071	CcSEcCtD
Etonogestrel—Pruritus—Lisinopril—systemic scleroderma	0.000292	0.000701	CcSEcCtD
Etonogestrel—Vomiting—Mycophenolic acid—systemic scleroderma	0.000291	0.000699	CcSEcCtD
Etonogestrel—Haemoglobin—Methotrexate—systemic scleroderma	0.00029	0.000696	CcSEcCtD
Etonogestrel—Rash—Mycophenolic acid—systemic scleroderma	0.000289	0.000693	CcSEcCtD
Etonogestrel—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000289	0.000693	CcSEcCtD
Etonogestrel—Haemorrhage—Methotrexate—systemic scleroderma	0.000288	0.000692	CcSEcCtD
Etonogestrel—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000287	0.000689	CcSEcCtD
Etonogestrel—Headache—Mycophenolic acid—systemic scleroderma	0.000287	0.000689	CcSEcCtD
Etonogestrel—Pharyngitis—Methotrexate—systemic scleroderma	0.000286	0.000687	CcSEcCtD
Etonogestrel—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000286	0.000686	CcSEcCtD
Etonogestrel—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000286	0.000686	CcSEcCtD
Etonogestrel—Nausea—Leflunomide—systemic scleroderma	0.000285	0.000685	CcSEcCtD
Etonogestrel—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000285	0.000683	CcSEcCtD
Etonogestrel—Urethral disorder—Methotrexate—systemic scleroderma	0.000283	0.000678	CcSEcCtD
Etonogestrel—Diarrhoea—Lisinopril—systemic scleroderma	0.000282	0.000678	CcSEcCtD
Etonogestrel—Ill-defined disorder—Prednisone—systemic scleroderma	0.000279	0.000669	CcSEcCtD
Etonogestrel—Visual impairment—Methotrexate—systemic scleroderma	0.000278	0.000667	CcSEcCtD
Etonogestrel—Angioedema—Prednisone—systemic scleroderma	0.000274	0.000659	CcSEcCtD
Etonogestrel—Dizziness—Lisinopril—systemic scleroderma	0.000273	0.000655	CcSEcCtD
Etonogestrel—Nausea—Mycophenolic acid—systemic scleroderma	0.000272	0.000653	CcSEcCtD
Etonogestrel—Malaise—Prednisone—systemic scleroderma	0.000271	0.00065	CcSEcCtD
Etonogestrel—Eye disorder—Methotrexate—systemic scleroderma	0.000269	0.000647	CcSEcCtD
Etonogestrel—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000266	0.000639	CcSEcCtD
Etonogestrel—Vomiting—Lisinopril—systemic scleroderma	0.000262	0.00063	CcSEcCtD
Etonogestrel—Angiopathy—Methotrexate—systemic scleroderma	0.000262	0.000628	CcSEcCtD
Etonogestrel—Immune system disorder—Methotrexate—systemic scleroderma	0.00026	0.000625	CcSEcCtD
Etonogestrel—Rash—Lisinopril—systemic scleroderma	0.00026	0.000625	CcSEcCtD
Etonogestrel—Convulsion—Prednisone—systemic scleroderma	0.00026	0.000625	CcSEcCtD
Etonogestrel—Dermatitis—Lisinopril—systemic scleroderma	0.00026	0.000624	CcSEcCtD
Etonogestrel—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000259	0.000623	CcSEcCtD
Etonogestrel—Hypertension—Prednisone—systemic scleroderma	0.000259	0.000622	CcSEcCtD
Etonogestrel—Headache—Lisinopril—systemic scleroderma	0.000259	0.000621	CcSEcCtD
Etonogestrel—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000256	0.000614	CcSEcCtD
Etonogestrel—Myalgia—Prednisone—systemic scleroderma	0.000256	0.000614	CcSEcCtD
Etonogestrel—Arthralgia—Prednisone—systemic scleroderma	0.000256	0.000614	CcSEcCtD
Etonogestrel—Anxiety—Prednisone—systemic scleroderma	0.000255	0.000612	CcSEcCtD
Etonogestrel—Alopecia—Methotrexate—systemic scleroderma	0.000255	0.000612	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000254	0.000609	CcSEcCtD
Etonogestrel—Discomfort—Prednisone—systemic scleroderma	0.000253	0.000606	CcSEcCtD
Etonogestrel—Mental disorder—Methotrexate—systemic scleroderma	0.000253	0.000606	CcSEcCtD
Etonogestrel—Erythema—Methotrexate—systemic scleroderma	0.000251	0.000602	CcSEcCtD
Etonogestrel—Malnutrition—Methotrexate—systemic scleroderma	0.000251	0.000602	CcSEcCtD
Etonogestrel—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000247	0.000594	CcSEcCtD
Etonogestrel—Nausea—Lisinopril—systemic scleroderma	0.000245	0.000588	CcSEcCtD
Etonogestrel—Oedema—Prednisone—systemic scleroderma	0.000245	0.000588	CcSEcCtD
Etonogestrel—Anaphylactic shock—Prednisone—systemic scleroderma	0.000245	0.000588	CcSEcCtD
Etonogestrel—Infection—Prednisone—systemic scleroderma	0.000243	0.000584	CcSEcCtD
Etonogestrel—Back pain—Methotrexate—systemic scleroderma	0.000243	0.000583	CcSEcCtD
Etonogestrel—Nervous system disorder—Prednisone—systemic scleroderma	0.00024	0.000577	CcSEcCtD
Etonogestrel—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000239	0.000574	CcSEcCtD
Etonogestrel—Skin disorder—Prednisone—systemic scleroderma	0.000238	0.000571	CcSEcCtD
Etonogestrel—Anorexia—Prednisone—systemic scleroderma	0.000234	0.000561	CcSEcCtD
Etonogestrel—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000233	0.000559	CcSEcCtD
Etonogestrel—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00023	0.000552	CcSEcCtD
Etonogestrel—Rash—Mycophenolate mofetil—systemic scleroderma	0.000228	0.000547	CcSEcCtD
Etonogestrel—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000228	0.000547	CcSEcCtD
Etonogestrel—Headache—Mycophenolate mofetil—systemic scleroderma	0.000227	0.000544	CcSEcCtD
Etonogestrel—Malaise—Methotrexate—systemic scleroderma	0.000226	0.000543	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000223	0.000536	CcSEcCtD
Etonogestrel—Insomnia—Prednisone—systemic scleroderma	0.000222	0.000532	CcSEcCtD
Etonogestrel—Paraesthesia—Prednisone—systemic scleroderma	0.00022	0.000528	CcSEcCtD
Etonogestrel—Cough—Methotrexate—systemic scleroderma	0.000219	0.000526	CcSEcCtD
Etonogestrel—Convulsion—Methotrexate—systemic scleroderma	0.000217	0.000522	CcSEcCtD
Etonogestrel—Dyspepsia—Prednisone—systemic scleroderma	0.000216	0.000518	CcSEcCtD
Etonogestrel—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000215	0.000516	CcSEcCtD
Etonogestrel—Myalgia—Methotrexate—systemic scleroderma	0.000214	0.000513	CcSEcCtD
Etonogestrel—Arthralgia—Methotrexate—systemic scleroderma	0.000214	0.000513	CcSEcCtD
Etonogestrel—Decreased appetite—Prednisone—systemic scleroderma	0.000213	0.000511	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000212	0.000509	CcSEcCtD
Etonogestrel—Fatigue—Prednisone—systemic scleroderma	0.000211	0.000507	CcSEcCtD
Etonogestrel—Discomfort—Methotrexate—systemic scleroderma	0.000211	0.000507	CcSEcCtD
Etonogestrel—Constipation—Prednisone—systemic scleroderma	0.00021	0.000503	CcSEcCtD
Etonogestrel—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000205	0.000492	CcSEcCtD
Etonogestrel—Infection—Methotrexate—systemic scleroderma	0.000203	0.000488	CcSEcCtD
Etonogestrel—Feeling abnormal—Prednisone—systemic scleroderma	0.000202	0.000485	CcSEcCtD
Etonogestrel—Nervous system disorder—Methotrexate—systemic scleroderma	0.000201	0.000482	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Prednisone—systemic scleroderma	0.0002	0.000481	CcSEcCtD
Etonogestrel—Skin disorder—Methotrexate—systemic scleroderma	0.000199	0.000478	CcSEcCtD
Etonogestrel—Anorexia—Methotrexate—systemic scleroderma	0.000195	0.000469	CcSEcCtD
Etonogestrel—Urticaria—Prednisone—systemic scleroderma	0.000195	0.000467	CcSEcCtD
Etonogestrel—Abdominal pain—Prednisone—systemic scleroderma	0.000194	0.000465	CcSEcCtD
Etonogestrel—Body temperature increased—Prednisone—systemic scleroderma	0.000194	0.000465	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000187	0.000448	CcSEcCtD
Etonogestrel—Insomnia—Methotrexate—systemic scleroderma	0.000185	0.000445	CcSEcCtD
Etonogestrel—Paraesthesia—Methotrexate—systemic scleroderma	0.000184	0.000441	CcSEcCtD
Etonogestrel—Somnolence—Methotrexate—systemic scleroderma	0.000182	0.000437	CcSEcCtD
Etonogestrel—Hypersensitivity—Prednisone—systemic scleroderma	0.000181	0.000433	CcSEcCtD
Etonogestrel—Dyspepsia—Methotrexate—systemic scleroderma	0.00018	0.000433	CcSEcCtD
Etonogestrel—Decreased appetite—Methotrexate—systemic scleroderma	0.000178	0.000427	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000177	0.000424	CcSEcCtD
Etonogestrel—Fatigue—Methotrexate—systemic scleroderma	0.000177	0.000424	CcSEcCtD
Etonogestrel—Asthenia—Prednisone—systemic scleroderma	0.000176	0.000422	CcSEcCtD
Etonogestrel—Pain—Methotrexate—systemic scleroderma	0.000175	0.00042	CcSEcCtD
Etonogestrel—Pruritus—Prednisone—systemic scleroderma	0.000173	0.000416	CcSEcCtD
Etonogestrel—Feeling abnormal—Methotrexate—systemic scleroderma	0.000169	0.000405	CcSEcCtD
Etonogestrel—Diarrhoea—Prednisone—systemic scleroderma	0.000168	0.000403	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000167	0.000402	CcSEcCtD
Etonogestrel—Urticaria—Methotrexate—systemic scleroderma	0.000163	0.000391	CcSEcCtD
Etonogestrel—Dizziness—Prednisone—systemic scleroderma	0.000162	0.000389	CcSEcCtD
Etonogestrel—Abdominal pain—Methotrexate—systemic scleroderma	0.000162	0.000389	CcSEcCtD
Etonogestrel—Body temperature increased—Methotrexate—systemic scleroderma	0.000162	0.000389	CcSEcCtD
Etonogestrel—Vomiting—Prednisone—systemic scleroderma	0.000156	0.000374	CcSEcCtD
Etonogestrel—Rash—Prednisone—systemic scleroderma	0.000155	0.000371	CcSEcCtD
Etonogestrel—Dermatitis—Prednisone—systemic scleroderma	0.000154	0.000371	CcSEcCtD
Etonogestrel—Headache—Prednisone—systemic scleroderma	0.000154	0.000369	CcSEcCtD
Etonogestrel—Hypersensitivity—Methotrexate—systemic scleroderma	0.000151	0.000362	CcSEcCtD
Etonogestrel—Asthenia—Methotrexate—systemic scleroderma	0.000147	0.000353	CcSEcCtD
Etonogestrel—Nausea—Prednisone—systemic scleroderma	0.000146	0.000349	CcSEcCtD
Etonogestrel—Pruritus—Methotrexate—systemic scleroderma	0.000145	0.000348	CcSEcCtD
Etonogestrel—Diarrhoea—Methotrexate—systemic scleroderma	0.00014	0.000336	CcSEcCtD
Etonogestrel—Dizziness—Methotrexate—systemic scleroderma	0.000135	0.000325	CcSEcCtD
Etonogestrel—Vomiting—Methotrexate—systemic scleroderma	0.00013	0.000313	CcSEcCtD
Etonogestrel—Rash—Methotrexate—systemic scleroderma	0.000129	0.00031	CcSEcCtD
Etonogestrel—Dermatitis—Methotrexate—systemic scleroderma	0.000129	0.00031	CcSEcCtD
Etonogestrel—Headache—Methotrexate—systemic scleroderma	0.000128	0.000308	CcSEcCtD
Etonogestrel—Nausea—Methotrexate—systemic scleroderma	0.000122	0.000292	CcSEcCtD
